Xuechao Wan

机构：CSPC Pharmaceutical Group · ORCID：0000-0001-8746-5545

发表论文 14 篇 · 总被引 616 次 · h-index 8

代表论文

• Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR‐29a‐3p (2019 · Journal of Cellular and Molecular Medicine · 被引 140)
• MIR93(microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy (2019 · Autophagy · 被引 129)
• Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer (2016 · Biomedicine & Pharmacotherapy · 被引 96)
• Overexpression of AR‐regulated lncRNA TMPO‐AS1 correlates with tumor progression and poor prognosis in prostate cancer (2018 · The Prostate · 被引 73)
• An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation (2017 · PLoS ONE · 被引 57)
• SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis (2018 · The International Journal of Biochemistry & Cell Biology · 被引 54)